Four-gene expression model predictive of lymph node metastases in oral squamous cell carcinoma

References

• De Bree R, Casteljins JA, Hoekstra OS, Leemans R. Advances in imaging in the work-up of head and neck cancer patients. Oral Oncol 2009;45:930–5.
   PubMed Web of Science ®Google Scholar
• Kocaturk S, Yilmazer D, Onal B, Erkam U, Urunal B. Do micrometastases detected with cytokeratin immunoperoxidase reactivity affect the treatment approach to neck in supraglottic cancers? Otolaryngol Head Neck Surg 2003;128:407–11.
   PubMed Web of Science ®Google Scholar
• Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, . Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004;5:489–500.
   PubMed Web of Science ®Google Scholar
• Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, Lijnzaad P, . An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 2005;37:182–6.
   PubMed Web of Science ®Google Scholar
• Kato Y, Uzawa K, Saito K, Nakashima D, Kato M, Nimura Y, . Gene expression pattern in oral cancer cervical lymph node metastasis. Oncol Rep 2006;16:1009–14.
   PubMed Web of Science ®Google Scholar
• Zhou X, Temam S, Oh M, Pungpravat N, Huang BL, Mao L, . Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma. Neoplasia 2006;8:925–32.
   PubMed Web of Science ®Google Scholar
• Nguyen ST, Hasegawa S, Tsuda H, Tomioka H, Ushijima M, Noda M, . Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma. Cancer Sci 2007;98:740–6.
   PubMed Web of Science ®Google Scholar
• Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992;257:967–71.
   PubMed Web of Science ®Google Scholar
• Mullis TC, Tang X, Chong KT. Expression of connective tissue growth factor (CTGF/CCN2) in head and neck squamous cell carcinoma. J Clin Pathol 2008;61:606–10.
   PubMed Web of Science ®Google Scholar
• Remmert S, Rottmann M, Reichenbach M, Sommer K, Friedrich HJ. Lymph node metastasis in head-neck tumors. Laryngorhinootologie 2001;80:27–35.
   PubMed Web of Science ®Google Scholar
• Jeon GA, Lee JS, Patel V, Gutkind JS, Thorgeirsson SS, Kim EC, . Global gene expression profiles of human head and neck squamous carcinoma cell lines. Int J Cancer 2004; 112:249–58.
   PubMed Web of Science ®Google Scholar
• Lemaire F, Millon R, Young J, Cromer A, Wasylyk C, Schultz I, . Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br J Cancer 2003;89:1940–9.
   PubMed Web of Science ®Google Scholar
• Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K, . Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001;61:889–95.
   PubMed Web of Science ®Google Scholar
• Izeradjene K, Douglas L, Delaney AB, Houghton JA. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Cancer Res 2004;64: 8036–44.
   PubMed Web of Science ®Google Scholar
• Guo X, Waddell DS, Wang W, Wang Z, Liberati NT, Yong S, . Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling. Oncogene 2008;27:7235–47.
   PubMed Web of Science ®Google Scholar
• Lu SL, Herrington H, Reh D, Weber S, Bornstein S, Wang D, . Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes Dev 2006;20:1331–42.
   PubMed Web of Science ®Google Scholar
• Mangone FR, Walder F, Maistro S, Pasini FS, Lehn CN, Carvalho MB, . Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients. Mol Cancer 2010;9:106–15.
   PubMed Web of Science ®Google Scholar
• Logullo AF, Nonogaki S, Miguel RE, Kowalski LP, Nishimoto IN, Pasini FS, . Transforming growth factor beta (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis. J Oral Pathol Med 2003;32:139–45.
   PubMed Web of Science ®Google Scholar
• Crombie R, Silverstein R. Lysosomal integral membrane protein II binds thrombospondin-1. Structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif. J Biol Chem 1998;273: 4855–63.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang X, Weng D, Tao S, Lv L, Chen J. A TSP-1 functional fragment inhibits activation of latent transforming growth factor-beta1 derived from rat alveolar macrophage after bleomycin treatment. Exp Toxicol Pathol 2009;61: 67–73.
   PubMedGoogle Scholar
• Parker F, Maurier F, Delumeau I, Duchesne M, Faucher D, Debussche L, . A Ras-GTPase-activating protein SH3-domain-binding protein. Mol Cell Biol 1996;16:2561–9.
   PubMed Web of Science ®Google Scholar
• Prigent M, Barlat I, Langen H, Dargemont C. IkappaBalpha and IkappaBalpha/NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, Ras GAP SH3-binding protein 2. J Biol Chem 2000;275: 36441–9.
   PubMed Web of Science ®Google Scholar
• Bindhu OS, Ramadas K, Sebastian P, Pillai MR. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma. Head Neck 2006;28:916–25.
   PubMed Web of Science ®Google Scholar
• Allen CT, Ricker JL, Chen Z, Van Waes C. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck. Head Neck 2007;29:959–71.
   PubMed Web of Science ®Google Scholar
• Wu WZ, Sun HC, Shen YF, Chen J, Wang L, Tang ZY, . Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways. J Cancer Res Clin Oncol 2005;131:169–78.
   PubMed Web of Science ®Google Scholar